Addressing Bias: Utilizing emerging therapeutics amidst fat-shaming

Rising rates of obesity and diabetes, drug shortages, patient demand and societal discussions around fat-shaming, have placed family physicians in a difficult position, at times acting as gatekeepers for medications, determining which patients should gain access to GLP-1 agonists. Broader societal discussion around what constitutes 'health' and 'overweight' may leave physicians feeling alone in grappling with these ethical decisions. Listen to our panel as they address their approach as stewards of these medications and share how they engage in these larger societal discussions. The Practising Well Community of Practice has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 1 Mainpro+Ⓡcredits. This Community of Practice includes a series of planned webinars. Each session is worth 1 Mainpro+Ⓡcredits, for up to a total of 12 credits. Panelists: Sean Wharton, MD, FRCPC, PharmD.  Assistant Professor University of Toronto, Clinician and Research in Obesity Medicine Stephanie Hart, Sexual Medicine physician and former full-scope rural family physician in southern Alberta Co-host: Nikki Bozinoff, Division Head, Mental Health and Addictions, Department of Family and Community Medicine, University of Toronto; Physician, Concurrent Outpatient Medical and Psychosocial Addiction Support Service, Centre for Addiction and Mental Health Moderator: Stephanie Zhou, Addictions Medicine Physician and EDI & Social Accountability Lead, Sunnybrook Hospital; FHO Lead, Don Mills FHT; Assistant Professor, University of Toronto Faculty of Medicine; Board Director, Toronto Public Health, Toronto, ON This session originally took place on May, 22, 2024. A recording can be viewed here.